XML 33 R2.htm IDEA: XBRL DOCUMENT v3.26.1
Pay vs Performance Disclosure
3 Months Ended 12 Months Ended
Dec. 27, 2025
USD ($)
Dec. 27, 2025
USD ($)
Dec. 28, 2024
USD ($)
Dec. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 25, 2021
USD ($)
Pay vs Performance Disclosure            
Pay vs Performance Disclosure, Table  
Pay versus Performance
Pursuant to SEC rules, the Pay versus Performance disclosure below details compensation for the Company’s CEO and average compensation for the other named executives, both as reported in the Summary Compensation Table and with certain adjustments to reflect compensation actually paid to such individuals in each of the Company’s fiscal years 2025, 2024, 2023, 2022 and 2021. The disclosure also provides
Please see Appendix A to this Proxy Statement for reconciliation of our GAAP EPS to non-GAAP EPS for 2016-2025.
Year
Summary
Compensation
Table Total
for CEO
($)
Compensation
Actually Paid
to CEO
($)(1)
Average
Summary
Compensation
Table Total for
Other Named
Executives
($)(2)
Average
Compensation
Actually paid to
Other Named
Executives
($)(1)
Value of Initial Fixed $100
Investment Based on(3)
Net income
available to
Charles River
Laboratories
International Inc.
common
shareholders
($)
Non- GAAP
EPS
($)
Total
Shareholder
Return
($)
Peer Group
Total
Shareholder
Return
($)
2025
15,435,220 24,913,934 3,560,900 4,410,976 81 148 (144,338,000) 10.28
2024
13,473,609 3,095,181 3,499,578 1,141,833 74 129 10,297,000 10.32
2023
14,096,924 20,468,880 3,692,047 4,926,154 94 126 474,624,000 10.67
2022
13,447,872 10,658,049 3,298,049 902,290 87 124 486,226,000 11.12
2021
13,705,580 41,201,427 4,392,906 8,866,839 147 126 390,982,000 10.32
(1)
SEC rules specify adjustments from the Summary Compensation Table totals to calculate compensation actually paid to the CEO and other named executives. These adjustments are detailed in the table below titled “Reconciliation of Summary Compensation Table Total to Compensation Actually Paid” but do not necessarily reflect cash or equity value transferred to the executive outright. The numbers in this table reflect an updated calculation methodology for PSUs that vested in the current year and Compensation Actually Paid for the years 2021-2024.
(2)
For 2021 through 2022, our named executives were: Mr. Foster, Mr. David Smith (former Chief Financial Officer), Mr. Barbo (former Corporate Executive Vice President and Chief Commercial Officer), Ms. Girshick and Mr. LaPlume. Ms. Pease became a named executive in 2022 when she assumed the role of Chief Financial Officer. For 2023, our named executive officers are: Mr. Foster, Ms. Pease, Mr. Barbo, Ms. Girshick and Mr. LaPlume. For 2024, our named executive officers are: Mr. Foster, Ms. Pease, Ms. Creamer, Ms. Girshick and Mr. LaPlume. For 2025, our named executive officers are: Mr. Foster, Ms. Pease, Ms. Creamer, Ms. Girshick, Mr. LaPlume and Mr. Knell. Mr. Knell became a named executive in 2025 when he assumed the role of Interim Chief Financial Officer.
(3)
TSR was measured for 2021 for the period from December 27, 2019 to December 23, 2021; for 2022 for the period from December 27, 2019 to December 30, 2022; for 2023 for the period from January 2, 2023 to December 29, 2023; for 2024 for the period of January 2, 2024 to December 27, 2024; and for 2025, for the period of December 30, 2024 to December 26, 2025. The peer group is the S&P 500 Health Care Index.
(4)
The table reflects net income on a GAAP basis. On a non-GAAP basis, net income for fiscal 2025 was $512.3 million. The primary driver of the GAAP decrease were non-cash intangible asset and goodwill impairments of $211.0 million and $165.0 million, respectively, in the fourth quarter of 2025.
Reconciliation of Summary Compensation Table Total to Compensation Actually Paid
The table below details the adjustments made to the total compensation paid as disclosed in the Summary Compensation to arrive at the compensation actually paid for our CEO and the average for our other named executives:
Year
Executive(s)
SCT Total
Deduct
Current
Year Equity
Grants(1)
Deduct
Change in
Value of
Pension or
Non-qualified
Deferred
Compensation
Earnings
from SCT(1)
Add
Pension
Value
Attributable
Current
Year’s
Service
Add Year
End Fair
Value of
Equity
Awards
Granted in
Current
Year(2)
Add Change
in Value of
Prior Years’
Grants that
Remained
Unvested at
Year End(3)
Add Change
in Value of
Prior Years’
Grants that
Vested in
Current
Year(4)
Compensation
Actually
Paid(5)
2025
CEO
15,435,220 11,601,089 1,000,717 19,144,088 865,363 69,635 24,913,934
Other Named
Executives
3,560,900 2,419,109 3,082,235 149,330 37,620 4,410,976
2024
CEO
13,473,609 11,226,634 866,253 9,530,080 (5,208,815) (4,339,313) 3,095,181
Other Named
Executives
3,499,578 2,594,656 2,233,247 (1,307,362) (688,974) 1,141,833
2023
CEO
14,096,924 11,433,096 788,969 14,598,471 476,837 1,940,775 20,468,880
Other Named
Executives
3,692,047 2,474,809 3,338,251 190,800 179,865 4,926,154
2022
CEO
13,447,872 10,939,883 989,746 7,459,567 (10,070,482) 9,771,230 10,658,049
Other Named
Executives
3,298,049 2,418,873 1,848,071 (1,380,356) (444,601) 902,290
2021
CEO
13,705,580 10,422,089 823,145 15,460,355 13,268,849 8,365,586 41,201,427
Other Named
Executives
4,392,906 3,203,012 3,965,695 2,276,985 1,434,265 8,866,839
(1)
These amounts were reported in the Stock Awards, Option Awards and Change in Pension Value and Non-qualified Deferred Compensation Earnings columns of our Summary Compensation Table included in our Proxy Statement in each respective year.
(2)
These values are calculated by valuing RSUs granted in the respective year with the stock price on the final trading day of that fiscal year, valuing PSUs granted in the respective year with the Monte Carlo value on the final trading day of that fiscal year plus the impact of EPS performance in the first year of the performance period and valuing options granted in the respective year with the Black-Scholes value on the final trading day of that fiscal year.
(3)
For any portion of a grant made prior to the respective year that remained unvested throughout that year, the value at the end of that year is compared to the value at the end of the prior year using the methodology described in footnote 2.
(4)
For any portion of a grant made prior to the respective year that vested in that year, the value of the vested portion as of the vest date is compared to the value at the end of the prior year using the methodology described in footnote 2. These numbers reflect an updated calculation methodology for PSUs that vested in the current year for the years 2021-2024.
       
Company Selected Measure Name   Non- GAAP EPS        
Named Executive Officers, Footnote  
(2)
For 2021 through 2022, our named executives were: Mr. Foster, Mr. David Smith (former Chief Financial Officer), Mr. Barbo (former Corporate Executive Vice President and Chief Commercial Officer), Ms. Girshick and Mr. LaPlume. Ms. Pease became a named executive in 2022 when she assumed the role of Chief Financial Officer. For 2023, our named executive officers are: Mr. Foster, Ms. Pease, Mr. Barbo, Ms. Girshick and Mr. LaPlume. For 2024, our named executive officers are: Mr. Foster, Ms. Pease, Ms. Creamer, Ms. Girshick and Mr. LaPlume. For 2025, our named executive officers are: Mr. Foster, Ms. Pease, Ms. Creamer, Ms. Girshick, Mr. LaPlume and Mr. Knell. Mr. Knell became a named executive in 2025 when he assumed the role of Interim Chief Financial Officer.
       
Peer Group Issuers, Footnote  
(3)
TSR was measured for 2021 for the period from December 27, 2019 to December 23, 2021; for 2022 for the period from December 27, 2019 to December 30, 2022; for 2023 for the period from January 2, 2023 to December 29, 2023; for 2024 for the period of January 2, 2024 to December 27, 2024; and for 2025, for the period of December 30, 2024 to December 26, 2025. The peer group is the S&P 500 Health Care Index.
       
PEO Total Compensation Amount   $ 15,435,220 $ 13,473,609 $ 14,096,924 $ 13,447,872 $ 13,705,580
PEO Actually Paid Compensation Amount   $ 24,913,934 3,095,181 20,468,880 10,658,049 41,201,427
Adjustment To PEO Compensation, Footnote  
Reconciliation of Summary Compensation Table Total to Compensation Actually Paid
The table below details the adjustments made to the total compensation paid as disclosed in the Summary Compensation to arrive at the compensation actually paid for our CEO and the average for our other named executives:
Year
Executive(s)
SCT Total
Deduct
Current
Year Equity
Grants(1)
Deduct
Change in
Value of
Pension or
Non-qualified
Deferred
Compensation
Earnings
from SCT(1)
Add
Pension
Value
Attributable
Current
Year’s
Service
Add Year
End Fair
Value of
Equity
Awards
Granted in
Current
Year(2)
Add Change
in Value of
Prior Years’
Grants that
Remained
Unvested at
Year End(3)
Add Change
in Value of
Prior Years’
Grants that
Vested in
Current
Year(4)
Compensation
Actually
Paid(5)
2025
CEO
15,435,220 11,601,089 1,000,717 19,144,088 865,363 69,635 24,913,934
Other Named
Executives
3,560,900 2,419,109 3,082,235 149,330 37,620 4,410,976
2024
CEO
13,473,609 11,226,634 866,253 9,530,080 (5,208,815) (4,339,313) 3,095,181
Other Named
Executives
3,499,578 2,594,656 2,233,247 (1,307,362) (688,974) 1,141,833
2023
CEO
14,096,924 11,433,096 788,969 14,598,471 476,837 1,940,775 20,468,880
Other Named
Executives
3,692,047 2,474,809 3,338,251 190,800 179,865 4,926,154
2022
CEO
13,447,872 10,939,883 989,746 7,459,567 (10,070,482) 9,771,230 10,658,049
Other Named
Executives
3,298,049 2,418,873 1,848,071 (1,380,356) (444,601) 902,290
2021
CEO
13,705,580 10,422,089 823,145 15,460,355 13,268,849 8,365,586 41,201,427
Other Named
Executives
4,392,906 3,203,012 3,965,695 2,276,985 1,434,265 8,866,839
(1)
These amounts were reported in the Stock Awards, Option Awards and Change in Pension Value and Non-qualified Deferred Compensation Earnings columns of our Summary Compensation Table included in our Proxy Statement in each respective year.
(2)
These values are calculated by valuing RSUs granted in the respective year with the stock price on the final trading day of that fiscal year, valuing PSUs granted in the respective year with the Monte Carlo value on the final trading day of that fiscal year plus the impact of EPS performance in the first year of the performance period and valuing options granted in the respective year with the Black-Scholes value on the final trading day of that fiscal year.
(3)
For any portion of a grant made prior to the respective year that remained unvested throughout that year, the value at the end of that year is compared to the value at the end of the prior year using the methodology described in footnote 2.
(4)
For any portion of a grant made prior to the respective year that vested in that year, the value of the vested portion as of the vest date is compared to the value at the end of the prior year using the methodology described in footnote 2. These numbers reflect an updated calculation methodology for PSUs that vested in the current year for the years 2021-2024.
       
Non-PEO NEO Average Total Compensation Amount   $ 3,560,900 3,499,578 3,692,047 3,298,049 4,392,906
Non-PEO NEO Average Compensation Actually Paid Amount   $ 4,410,976 1,141,833 4,926,154 902,290 8,866,839
Adjustment to Non-PEO NEO Compensation Footnote  
Reconciliation of Summary Compensation Table Total to Compensation Actually Paid
The table below details the adjustments made to the total compensation paid as disclosed in the Summary Compensation to arrive at the compensation actually paid for our CEO and the average for our other named executives:
Year
Executive(s)
SCT Total
Deduct
Current
Year Equity
Grants(1)
Deduct
Change in
Value of
Pension or
Non-qualified
Deferred
Compensation
Earnings
from SCT(1)
Add
Pension
Value
Attributable
Current
Year’s
Service
Add Year
End Fair
Value of
Equity
Awards
Granted in
Current
Year(2)
Add Change
in Value of
Prior Years’
Grants that
Remained
Unvested at
Year End(3)
Add Change
in Value of
Prior Years’
Grants that
Vested in
Current
Year(4)
Compensation
Actually
Paid(5)
2025
CEO
15,435,220 11,601,089 1,000,717 19,144,088 865,363 69,635 24,913,934
Other Named
Executives
3,560,900 2,419,109 3,082,235 149,330 37,620 4,410,976
2024
CEO
13,473,609 11,226,634 866,253 9,530,080 (5,208,815) (4,339,313) 3,095,181
Other Named
Executives
3,499,578 2,594,656 2,233,247 (1,307,362) (688,974) 1,141,833
2023
CEO
14,096,924 11,433,096 788,969 14,598,471 476,837 1,940,775 20,468,880
Other Named
Executives
3,692,047 2,474,809 3,338,251 190,800 179,865 4,926,154
2022
CEO
13,447,872 10,939,883 989,746 7,459,567 (10,070,482) 9,771,230 10,658,049
Other Named
Executives
3,298,049 2,418,873 1,848,071 (1,380,356) (444,601) 902,290
2021
CEO
13,705,580 10,422,089 823,145 15,460,355 13,268,849 8,365,586 41,201,427
Other Named
Executives
4,392,906 3,203,012 3,965,695 2,276,985 1,434,265 8,866,839
(1)
These amounts were reported in the Stock Awards, Option Awards and Change in Pension Value and Non-qualified Deferred Compensation Earnings columns of our Summary Compensation Table included in our Proxy Statement in each respective year.
(2)
These values are calculated by valuing RSUs granted in the respective year with the stock price on the final trading day of that fiscal year, valuing PSUs granted in the respective year with the Monte Carlo value on the final trading day of that fiscal year plus the impact of EPS performance in the first year of the performance period and valuing options granted in the respective year with the Black-Scholes value on the final trading day of that fiscal year.
(3)
For any portion of a grant made prior to the respective year that remained unvested throughout that year, the value at the end of that year is compared to the value at the end of the prior year using the methodology described in footnote 2.
(4)
For any portion of a grant made prior to the respective year that vested in that year, the value of the vested portion as of the vest date is compared to the value at the end of the prior year using the methodology described in footnote 2. These numbers reflect an updated calculation methodology for PSUs that vested in the current year for the years 2021-2024
       
Compensation Actually Paid vs. Total Shareholder Return  
[MISSING IMAGE: bc_tsr-bw.jpg]
       
Compensation Actually Paid vs. Net Income  
[MISSING IMAGE: bc_netincome-bw.jpg]
       
Compensation Actually Paid vs. Company Selected Measure  
[MISSING IMAGE: bc_nongappeps-bw.jpg]
       
Total Shareholder Return Vs Peer Group  
[MISSING IMAGE: lc_crltsr-bw.jpg]
       
Tabular List, Table  
The three measures listed below are the most important for determining compensation for our named executives. Revenue and Non-GAAP Operating Income are the main components of EICP (short-term incentive), and Non-GAAP EPS determines baseline performance of PSUs granted to our named executives (long-term incentive). For more details on the elements of our compensation program, please see “Compensation Discussion and Analysis—Compensation Elements” on pages 49-58 of this Proxy Statement.
Most Important
Performance Measures
Revenue
Non-GAAP EPS
Non-GAAP Operating Income
       
Total Shareholder Return Amount   $ 81 74 94 87 147
Peer Group Total Shareholder Return Amount   148 129 126 124 126
Net Income (Loss)   $ (144,338,000) $ 10,297,000 $ 474,624,000 $ 486,226,000 $ 390,982,000
Company Selected Measure Amount   10.28 10.32 10.67 11.12 10.32
PEO Name   Mr. Foster        
Non Gaap Net income Loss   $ 512,300,000        
Impairment of Intangible Assets, Finite-Lived $ 211,000,000          
Goodwill, Impairment Loss $ 165,000,000          
Measure:: 1            
Pay vs Performance Disclosure            
Name   Revenue        
Measure:: 2            
Pay vs Performance Disclosure            
Name   Non-GAAP EPS        
Non-GAAP Measure Description  
(4)
The table reflects net income on a GAAP basis. On a non-GAAP basis, net income for fiscal 2025 was $512.3 million. The primary driver of the GAAP decrease were non-cash intangible asset and goodwill impairments of $211.0 million and $165.0 million, respectively, in the fourth quarter of 2025.
       
Measure:: 3            
Pay vs Performance Disclosure            
Name   Non-GAAP Operating Income        
PEO | Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table            
Pay vs Performance Disclosure            
Adjustment to Compensation, Amount  
PEO | Pension Adjustments Prior Service Cost            
Pay vs Performance Disclosure            
Adjustment to Compensation, Amount   1,000,717 866,253 788,969 989,746 823,145
PEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table            
Pay vs Performance Disclosure            
Adjustment to Compensation, Amount   (11,601,089) (11,226,634) (11,433,096) (10,939,883) (10,422,089)
PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested            
Pay vs Performance Disclosure            
Adjustment to Compensation, Amount   19,144,088 9,530,080 14,598,471 7,459,567 15,460,355
PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested            
Pay vs Performance Disclosure            
Adjustment to Compensation, Amount   865,363 (5,208,815) 476,837 (10,070,482) 13,268,849
PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year            
Pay vs Performance Disclosure            
Adjustment to Compensation, Amount   69,635 (4,339,313) 1,940,775 9,771,230 8,365,586
Non-PEO NEO | Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table            
Pay vs Performance Disclosure            
Adjustment to Compensation, Amount  
Non-PEO NEO | Pension Adjustments Prior Service Cost            
Pay vs Performance Disclosure            
Adjustment to Compensation, Amount  
Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table            
Pay vs Performance Disclosure            
Adjustment to Compensation, Amount   (2,419,109) (2,594,656) (2,474,809) (2,418,873) (3,203,012)
Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested            
Pay vs Performance Disclosure            
Adjustment to Compensation, Amount   3,082,235 2,233,247 3,338,251 1,848,071 3,965,695
Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested            
Pay vs Performance Disclosure            
Adjustment to Compensation, Amount   149,330 (1,307,362) 190,800 (1,380,356) 2,276,985
Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year            
Pay vs Performance Disclosure            
Adjustment to Compensation, Amount   $ 37,620 $ (688,974) $ 179,865 $ (444,601) $ 1,434,265